HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Previous close
$0.57
Day range
$0.55 - $0.58
Year range
$0.52 - $1.06
Market cap
25.31M CAD
Avg Volume
13.73K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 677.78K | -38.12% |
Net income | -656.86K | 37.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.15M | 14.19% |
Total assets | 4.25M | 15.39% |
Total liabilities | 105.92K | -66.95% |
Total equity | 4.15M | — |
Shares outstanding | 45.51M | — |
Price to book | 6.33 | — |
Return on assets | -36.37% | — |
Return on capital | -38.06% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -656.86K | 37.71% |
Cash from operations | -834.90K | 15.81% |
Cash from investing | — | — |
Cash from financing | 7.00K | — |
Net change in cash | -823.21K | 18.57% |
Free cash flow | -601.65K | 3.22% |
About
Founded
2018
Headquarters
Website
